Phase 1 Relapsed Advanced Lymphomas Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)
Relapsed Advanced Lymphomas
Aurigene Discovery Technologies Limited40 enrolled27 locationsNCT05984147
Recruiting
Phase 1
Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma
Relapsed Advanced Lymphomas
Aurigene Discovery Technologies Limited40 enrolled19 locationsNCT06755450